fluorobenzenes has been researched along with Neurofibromatosis 1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bessler, WK; Conway, SJ; DiStasi, MR; Downing, B; Ingram, DA; Kapur, R; Li, F; Mali, R; Mund, JA; Sarchet, KN; Stansfield, BK | 1 |
1 other study(ies) available for fluorobenzenes and Neurofibromatosis 1
Article | Year |
---|---|
Heterozygous inactivation of the Nf1 gene in myeloid cells enhances neointima formation via a rosuvastatin-sensitive cellular pathway.
Topics: Animals; Anti-Inflammatory Agents; Arterial Occlusive Diseases; Bone Marrow Cells; Fluorobenzenes; Heterozygote; Humans; Macrophages; Metabolic Networks and Pathways; Mice; Myeloid Cells; Neointima; Neurofibromatosis 1; Neurofibromin 1; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2013 |